Stoke Therapeutics Inc.
STOK | NASDAQ
$28.92
+$0.87 (+3.10%)
Sep 22, 2026, 11:29 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 27.59M | 32.08M | 184.42M | 205.63M | 199.89M | 190.91M | 36.56M | 16.74M | 15.16M | 7.85M | 8.78M | 9.25M | 8.85M | 14.56M | 12.41M | 9.14M | 6.23M | 3M | n/a | n/a | n/a | n/a |
Cost of Revenue | 4.23M | 3.09M | 2.04M | 989K | n/a | 1.11M | 2.22M | 3.44M | 4.64M | 4.7M | 4.73M | 4.67M | 4.39M | 4.06M | 3.54M | 2.38M | 1.46M | 624K | n/a | n/a | n/a | n/a |
Gross Profit | 23.36M | 28.99M | 182.38M | 204.64M | 199.89M | 189.8M | 34.33M | 13.31M | 10.52M | 3.15M | 4.05M | 4.58M | 4.46M | 10.5M | 8.87M | 6.75M | 4.77M | 2.38M | n/a | n/a | n/a | n/a |
Operating Income | -223.38M | -185.25M | -20.59M | 27.2M | 40.28M | 38.24M | -101.37M | -117.3M | -114.53M | -118.45M | -114.77M | -112.36M | -112.28M | -104.25M | -104.36M | -101.71M | -97.24M | -94.03M | -86.07M | -76.13M | -67.15M | -58.14M |
Interest Income | 14.02M | 14.3M | 13.77M | 13.12M | 13.2M | 13.1M | 12.64M | 12.25M | 11.36M | 10.23M | 9.91M | 8.8M | 7.14M | 5.12M | 3.12M | 1.68M | 728K | 218K | 132K | 106K | 73K | 89K |
Pretax Income | -209.18M | -171.05M | -6.89M | 40.57M | 53.76M | 51.55M | -88.98M | -105.46M | -103.57M | -108.53M | -104.7M | -103.4M | -104.97M | -98.96M | -101.07M | -99.86M | -96.35M | -93.66M | -85.81M | -75.92M | -67.01M | -58M |
Net Income | -207.9M | -169.77M | -6.89M | 40.57M | 52.48M | 50.27M | -88.98M | -105.46M | -103.57M | -108.53M | -104.7M | -103.4M | -104.97M | -98.96M | -101.07M | -99.86M | -96.35M | -93.66M | -85.81M | -75.92M | -67.01M | -58M |
Selling & General & Admin | 80.52M | 71.21M | 65.89M | 58.24M | 55.45M | 52.66M | 47.68M | 44.86M | 41.87M | 39.07M | 39.06M | 37.88M | 37.58M | 37.49M | 36.94M | 36.82M | 35.74M | 34.09M | 31.9M | 28.85M | 26.13M | 23.24M |
Research & Development | 167.26M | 144.07M | 137.08M | 119.21M | 104.16M | 98.89M | 88.02M | 85.75M | 83.18M | 82.53M | 79.76M | 79.06M | 79.15M | 77.26M | 76.29M | 71.64M | 66.28M | 62.32M | 54.17M | 47.27M | 41.02M | 34.89M |
Other Expenses | -1.05M | -1.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1 | 1 | 1 | 1 | n/a | n/a |
Operating Expenses | 246.74M | 214.24M | 202.97M | 177.45M | 159.61M | 151.56M | 135.7M | 130.61M | 125.05M | 121.6M | 118.82M | 116.94M | 116.73M | 114.75M | 113.23M | 108.46M | 102.01M | 96.41M | 86.07M | 76.13M | 67.15M | 58.14M |
Interest Expense | 46K | 32K | 10K | 7K | 4K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -562K | -1.11M | -1.7M | -1.7M | -1.14M | -591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 250.97M | 217.33M | 205.01M | 178.44M | 159.61M | 152.67M | 137.93M | 134.05M | 129.69M | 126.3M | 123.55M | 121.61M | 121.12M | 118.81M | 116.76M | 110.84M | 103.47M | 97.03M | 86.07M | 76.13M | 67.15M | 58.14M |
Income Tax Expense | -1.28M | -1.28M | n/a | n/a | 1.28M | 1.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 66.02M | 63.06M | 58.39M | 58.61M | 58.35M | 57.86M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
Shares Outstanding (Diluted) | 66.02M | 63.06M | 58.39M | 58.61M | 58.35M | 59.4M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
EPS (Basic) | -3.36 | -2.83 | -0.09 | 0.72 | 0.90 | 0.84 | -1.68 | -2.10 | -2.18 | -2.41 | -2.27 | -2.23 | -2.29 | -2.19 | -2.41 | -2.51 | -2.51 | -2.52 | -2.33 | -2.09 | -1.89 | -1.68 |
EPS (Diluted) | -3.36 | -2.83 | -0.14 | 0.67 | 0.85 | 0.79 | -1.68 | -2.10 | -2.18 | -2.41 | -2.27 | -2.23 | -2.29 | -2.19 | -2.41 | -2.51 | -2.51 | -2.52 | -2.33 | -2.09 | -1.89 | -1.68 |
EBITDA | -205.36M | -164.11M | -3.91M | 43.01M | 55.75M | 53.64M | -86.8M | -103.18M | -100.63M | -104.97M | -100.56M | -98.73M | -100.58M | -94.91M | -97.53M | -97.24M | -94.4M | -92.3M | -84.87M | -75M | -66.14M | -57.21M |
EBIT | -209.59M | -167.64M | -6.88M | 40.57M | 53.76M | 51.55M | -88.98M | -105.46M | -103.57M | -108.53M | -104.7M | -103.4M | -104.97M | -98.96M | -101.07M | -99.86M | -96.35M | -93.66M | -85.84M | -75.98M | -67.09M | -58.14M |
Depreciation & Amortization | 4.23M | 3.54M | 2.97M | 2.44M | 1.99M | 2.09M | 2.18M | 2.28M | 2.94M | 3.55M | 4.14M | 4.67M | 4.39M | 4.06M | 3.54M | 2.62M | 1.95M | 1.36M | 974K | 976K | 956K | 931K |
Add to Watchlist
Select watchlists to add or remove STOK